View of Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies

Return to Article Details Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies Download Download PDF